Anixa Biosciences, Inc.

Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Technologies
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Cancer Vaccines
      • Introduction
      • Markets
      • Science
      • Collaborators
    • COVID-19
      • Introduction
      • Science
      • Collaborators
  • Pipeline
  • Investors
    • Overview
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Publications
  • Contact Us

News Releases

Investors

Investors

  • Overview
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • RSS News Feed
  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

ITUS Corporation Terminates At-The-Market Offering

December 12, 2017

ITUS Will Present Data on Early Cancer Detection Technology at ASCO-SITC Symposium

December 6, 2017

ITUS Receives Notice of Allowance for Second Key Cancer Technology Patent

November 28, 2017

ITUS Conference Call Recording Available on Company Website

November 22, 2017

ITUS Will Hold Conference Call to Discuss its CAR-T Cancer Therapeutics Program

November 21, 2017

ITUS Enters CAR-T Research Alliance with Moffitt Cancer Center

November 20, 2017

ITUS Corporation Licenses CAR-T Technology from The Wistar Institute

November 14, 2017

ITUS Corporation Pays Off Secured Debenture

October 27, 2017

ITUS Receives Notice of NASDAQ Continued Listing Compliance

October 3, 2017

ITUS Corporation Completes At-the-Market Offering

October 2, 2017

RSS
  • 1
  • 2
  • 3
  • 4
  • Next »

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Jun 21, 2022

Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Clinical and Experimental Vaccine Research Highlighting Ovarian Cancer Vaccine Technology

Read More...
May 5, 2022

Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference

Read More...
Apr 28, 2022

Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting

Read More...
Copyrights © 2022 Anixa Biosciences, Inc.. All Rights Reserved.
Privacy Policy Disclaimer Sitemap